Joshua M Staley
5PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 02, 2026
ER2Net: an evidential reasoning rule-enabled neural network for reliable triple-negative breast cancer tumor segmentation in magnetic resonance imaging.Kazi Md Farhad Mahmud, Ahmad Qasem, Joshua M Staley
|Mar 11, 2024
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy.Miguel Martín, Rachel Yoder, Roberto Salgado
|Mar 06, 2023
ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease.Shane R Stecklein, Bruce F Kimler, Rachel Yoder
|Jul 11, 2022
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer.Rachel Yoder, Bruce F Kimler, Joshua M Staley
|Nov 19, 2020
Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP).Priyanka Sharma, Bruce F Kimler, Anne O'Dea
Pageof 1
Frequent Collaborators
4 joint publications
Andrew K Godwin
3 joint publications
Bruce F Kimler
3 joint publications
Shane R Stecklein
3 joint publications
Qamar J Khan
3 joint publications
Priyanka Sharma
1 joint publications
Amanda L Amin
1 joint publications
Kelsey Larson
1 joint publications
Christa Balanoff
1 joint publications
Dinesh Pal Mudaranthakam
1 joint publications
Roy A Jensen
